Programmed bacteria to kill cancer

Ernest Pharmaceuticals is a biotechnology company that is developing a state-of-the-art bacterial therapies to treat advanced solid tumors. The foundational technology for Ernest’s revolutionary platform was spun out of UMass Amherst and has the potential to change the lifes of patients that currently don’t have any treatment options.